BrightSpire Capital: Barclays Downgrades Underweight to Equal-Weight, PT to $5.
In a significant move, Barclays has upgraded BrightSpire Capital (NYSE:BRSP) from Underweight to Equalweight, adjusting its price target from $5.00 to $7.00. The stock, currently trading at $5.12 with a market cap of $668 million, has shown significant volatility according to InvestingPro data [1][2].
The upgrade comes despite the investment bank's earlier concerns about the challenging reinvestment backdrop, which posed risks to the company’s growth targets and potentially pressured dividend coverage. Barclays noted that BrightSpire Capital needs to grow its portfolio from the current $2.5 billion to over $3 billion to maintain its 16-cent quarterly dividend, and potentially to $3.5 billion or more to increase it [1][2].
However, Barclays acknowledged the improving pipeline of deals observed by management, although it noted that relatively few deals in the pipeline are actionable with favorable returns. This is expected to limit any material multiple re-rating, leading to the expectation that BRSP will underperform relative to other mortgage stocks in its coverage [1][2].
BrightSpire Capital recently reported its first-quarter 2025 earnings, showing earnings per share (EPS) of $0.16, falling short of the anticipated $0.18. The company’s revenue for the quarter was in line with expectations, totaling $63.66 million. Despite the earnings miss, BrightSpire Capital remains committed to maintaining its dividend and is targeting $1 billion in net portfolio growth. Additionally, the company announced a quarterly dividend of $0.16 per share for the second quarter of 2025 [1][2].
During its annual stockholders meeting, several important decisions were made, including the election of directors and the approval of executive compensation. Shareholders also ratified Deloitte & Touche LLP as the independent auditor for the fiscal year ending December 31, 2025. Furthermore, BrightSpire Capital continues to navigate a challenging market environment, focusing on strategic growth and portfolio management. The company is also planning a CLO issuance for the fourth quarter of 2025 to support its growth initiatives [1][2].
These developments highlight BrightSpire Capital’s ongoing efforts to strengthen its financial position and adapt to market conditions. Investors should closely monitor the company's progress and the execution of its strategic plans.
References:
[1] https://uk.investing.com/news/analyst-ratings/barclays-downgrades-bright-spire-capital-stock-on-dividend-coverage-risks-93CH-4160190
[2] https://www.investing.com/news/analyst-ratings/barclays-downgrades-bright-spire-capital-stock-on-dividend-coverage-risks-93CH-4125817
Comments
No comments yet